I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A Pilot Study of Silymarin as Supplementation to Reduce Tox..:
Chang, Tsung-Kun
;
Yin, Tzu-Chieh
;
Su, Wei-Chih
...
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 28 (2021) 7 - p. 801-809 , 2021
Link:
https://doi.org/10.3727/096504021x16218531628569
RT Journal T1
A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab
UL https://suche.suub.uni-bremen.de/peid=cr-10.3727_096504021x16218531628569&Exemplar=1&LAN=DE A1 Chang, Tsung-Kun A1 Yin, Tzu-Chieh A1 Su, Wei-Chih A1 Tsai, Hsiang-Lin A1 Huang, Ching-Wen A1 Chen, Yen-Cheng A1 Li, Ching-Chun A1 Chen, Po-Jung A1 Ma, Cheng-Jen A1 Chuang, Kuo-Hsiang A1 Cheng, Tian-Lu A1 Wang, Jaw-Yuan PB Computers, Materials and Continua (Tech Science Press) YR 2021 SN 0965-0407 JF Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics VO 28 IS 7 SP 801 OP 809 LK http://dx.doi.org/https://doi.org/10.3727/096504021x16218531628569 DO https://doi.org/10.3727/096504021x16218531628569 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)